Podcasts about Clinical

There's been a lot of focus lately on how much ‘screen time' children have and how technology is negatively impacting them. But scrolling on a cell phone all day is also terrible for adults. This is why many are making the case that both adults and children do a ‘digital detox' in 2026. Clinical psychologist and family therapist Dr. Sheryl Ziegler explains how damaging cell phones and social media have been for people of all ages, and offers tips on unplugging and improving mental health by avoiding the traps of modern tech. Then, we revisit one of our most impactful interviews from the past year, when Chairman of the House Intelligence Committee, Rep. Rick Crawford (AR-01) joined Mike Emanuel to react to President Trump's bold decision to bomb three Iranian nuclear sites this past June. Plus, commentary by Chuck DeVore, chief national initiatives officer with the Texas Public Policy Foundation. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Are you ready to feel grounded, energized, and confident in your wellness this year? Are you tired of starting January with restriction instead of nourishment? Do you want habits that actually stick and support your metabolism, hormones, and mental health? In this episode, Ali and Becki kick off the new year by sharing five foundational ways to invest in your wellness so your routines feel craveworthy, not forced. We discuss how pleasure, satisfaction, and real food are essential for sustainability, how to navigate cravings without shame, and why creating routines your body desires leads to lasting change. We also dive into supporting detox pathways, balancing blood sugar, and understanding how hormonal shifts—especially changes in estrogen—impact insulin sensitivity and metabolism as women age. Ali and Becki cover practical strategies for metabolic flexibility, the role of gratitude in nervous system and metabolic regulation, and why getting outside daily may be one of the most powerful (and overlooked) tools for stress resilience and healing.  Also in this episode:  Keto Reset Masterclass: 1/7/26 at 12pm CST  10-day Detox Masterclass: 1/5/26 at 12pm CST Keto Reset Program use code RESET75 Make your wellness craveworthy Super Greens Cubes FOND Bone Broth use code ALIMILLERRD Red Light Mask LumeBox Red Light use code BECKIYOO PEMF & Red Light Mat use code BeckiYoo10fs Addressing food cravings Naturally Nourished Episode 472 Good, Better, Best with Brenda … You Glow Girl Tea Support Your Detox Pathways E3 Live Beam Minerals Cellular Antiox Balance Your Blood Sugar The Role of Estrogen in Insulin Resistance: A Review of Clinical and Preclinical Data - ScienceDirect Naturally Nourished Episode 395 Testing Women's Hormones KetoMojo Nutrisense Practice Gratitude Naturally Nourished Episode 164 Make Positivity Louder and Keto … Work with Becki use code BECKIPACK for 10% off Get Outside Naturally Nourished Episode 424 How Daily Walking Can Transform … Naturally Nourished Episode 322 Nature as Medicine | Ali Miller RD Ali & Becki's Words for the Year Emerging Trends in the Wellness Space EMF Mitigation Aires Tech This episode is sponsored by the Naturally Nourished Food-as-Medicine Keto Reset. Our Keto Reset is a 12-week, real-food, functional medicine–based program designed to help you lower insulin, improve metabolic flexibility, and address the root causes behind stubborn weight loss, hormone imbalance, gut dysfunction, and chronic inflammation. Unlike traditional keto plans, this program focuses on macronutrient strategy over calorie obsession, antioxidant density, therapeutic foods, and high-quality sourcing—while eliminating ultra-processed foods and non-caloric sweeteners. The goal isn't restriction or perfection, but teaching your body how to burn fat efficiently while feeling nourished and supported. Throughout the program, you'll learn how to personalize your approach using sliding-scale protocols, understand how stress, hormones, and blood sugar influence metabolism, and build sustainable habits that lead to true food freedom. With weekly live classes, Q&As, and access to Ali and Becki's combined 20+ years of functional medicine experience, the Keto Reset is designed to work with your physiology—not against it—so you can finally feel confident, clear, and in control of your health. Join us now, use code RESET75 to save  

Send us a textAs 2025 comes to a close, Ben and Daphna reflect on a year of growth, community, and evolution for The Incubator Podcast. In this end-of-year wrap-up, they preview major changes coming in 2026, including new standalone podcast feeds, expanded journal club content, CME opportunities, and exciting partnerships with organizations like the Vermont Oxford Network and PAS. They also share what's ahead for the Delphi Conference and offer a candid look at their personal and professional goals for the year ahead. Thank you for being part of this extraordinary neonatal community. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Calling out "Happy Christmas to all and to all a good-night,  Dr. Griffin and Vincent Racaniello discuss high path influenza in dairy herds in Wisconsin and Marburg virus in Ethiopia before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, the slightly higher association of COVID-19 infection with death than following influenza infection, benefit of passive infant immunization with niresevimab, association of COVID-19 vaccine immunogenicity protection against severe disease in vulnerable populations, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, effect of remdesivir and nirmatrelvir/ritonavir on COVID-19 associated mortality, where to go for answers to your long COVID questions, and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode USDA Confirms Highly Pathogenic Avian Influenza in a Dairy Herd in Wisconsin (USDA Animal and Plant Health Inspection Service) Update: Genetic Sequencing Results for Wisconsin Dairy Herd Detection of Highly Pathogenic Avian Influenza(USDA Animal and Plant Health Inspection Service) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely(CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Increased 30-day Mortality Risk in Coronavirus Disease 2019 Compared to Seasonal Influenza (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus–Related Hospitalization in Newborns (JAMA) RSV Immunization Frequently Asked Questions(American Academy of Pediatrics) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Association between COVID-19 vaccine immunogenicity and protection against infection and severe disease in clinically vulnerable patient populations: a systematic review and meta-analysis of observational studies (Clinical Microbiology and Infection) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) The effect of remdesivir and nirmatrelvir/ritonavir on mortality in patients hospitalized with COVID-19 during the Omicron era: an emulated target trial (Clinical Microbiology and Infection) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments? (Nature) Reaching out to US house representative Letters read on TWiV 1282 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Clinical hypnotherapist and best-selling author, Fiona Brennan, joins Sean Defoe to share some simple mind-based hacks to help you fall asleep faster and wake up properly rested in the New Year.

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Dyane Tower to Dean's Chat. This episode is sponsored by the American Podiatric Medical Association (APMA)! Dyane Tower, DPM, MPH, MS, CAE is a nationally recognized leader in podiatric medicine and healthcare administration, currently serving as Medical Director and Vice President of Clinical Affairs for the American Podiatric Medical Association (APMA). With a unique blend of clinical training and executive leadership, Dr. Tower plays a pivotal role in shaping national clinical policy, professional standards, and advocacy efforts for the podiatric profession. She holds the degrees of Doctor of Podiatric Medicine degree from the Scholl College of Podiatric Medicine, and completed her 3 year residency at the North Coloroado Podiatric Medicine Surgery program. Her background highlights advanced expertise in organizational governance, strategy, and healthcare leadership. Her interdisciplinary background allows her to bridge clinical practice, public health, and national-level professional advocacy. At APMA, Dr. Tower oversees: • Clinical policy and professional practice standards • Clinical education and evidence-based guidelines • Regulatory affairs and federal advocacy • Public health integration and interdisciplinary collaboration Dr. Tower is widely respected for her strategic vision, clarity of communication, and deep commitment to advancing podiatric medicine at a national level. As a featured guest on Dean's Chat, she provides expert insight into healthcare policy, clinical governance, professional advocacy, and the future direction of the podiatric profession. Beyond her executive leadership, Dr. Tower is known for her mentorship, national speaking engagements, and ongoing efforts to elevate the voice and visibility of podiatric physicians within the broader healthcare ecosystem. Enjoy!

Welcome to the NeurologyLive® Mind Moments® podcast. Tune in to hear leaders in neurology sound off on topics that impact your clinical practice. In this episode, "Clinical Advances and Unanswered Questions in Narcolepsy," Lindsay McCullough, MD, discusses how clinical understanding of narcolepsy has evolved, where major diagnostic and treatment advances have occurred, and where important gaps remain. McCullough, assistant professor of medicine and associate program director for the sleep medicine fellowship at Rush University, reflects on progress in defining narcolepsy subtypes, the growing role of orexin biology, and how recent research in 2025 has reshaped conversations around disease-modifying approaches. The discussion also explores emerging links between sleep disorders and neurodegenerative disease, common misconceptions that continue to delay diagnosis, and how clinician education can improve recognition, safety, and long-term management of patients with narcolepsy. Looking for more Sleep Disorder discussion? Check out the NeurologyLive® Sleep Disorder clinical focus page. Episode Breakdown: 1:05 – Advances and remaining gaps in the clinical understanding of narcolepsy 2:30 – How narcolepsy care and research meaningfully evolved throughout 2025 4:50 – Sleep disorders, neurodegeneration, and what clinicians should watch for 6:50 – Neurology News Minute 8:50 – Persistent myths that delay diagnosis and affect clinical decision-making 12:30 – How lived experience shapes holistic, patient-centered narcolepsy care The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here: FDA Approves Inebilizumab for AChR- and MuSK-Positive Generalized Myasthenia Gravis FDA Clears Pivotal Phase 3 PREVAiLS Study of Pridopidine in Early, Rapidly Progressive ALS Tolebrutinib Falls Short in Phase 3 PERSEUS Study, Forcing Decision to Redact Regulatory Submission Thanks for listening to the NeurologyLive® Mind Moments® podcast. To support the show, be sure to rate, review, and subscribe wherever you listen to podcasts. For more neurology news and expert-driven content, visit neurologylive.com.

Endocrine Surgery emergencies are rare. However, they can be clinically significant and understanding how to navigate them as a surgeon in timely fashion is critical. Hosts:  Dr. Rebecca Sippel is an endowed professor of surgery and Division Chief of Endocrine Surgery at University of Wisconsin (UW) - Madison, and she is the most recent past president of the American Association of Endocrine Surgeons (AAES).  She is an internationally recognized leader in the field of endocrine surgery with over 250 publications. She was the principal investigator for a hallmark randomized controlled trial which studied the need for prophylactic central neck dissections in thyroid cancer.   Dr. Amanda Doubleday is a fellowship trained endocrine surgeon in private practice with an affiliation to UW Health. Her primary practice is with Waukesha Surgical Specialists in Waukesha WI. Her clinical interests are in robotic adrenalectomy, benign and malignant thyroid cancer and hyperparathyroidism. Dr. Simon Holoubek is a fellowship trained endocrine surgeon affiliated with UW Health. His primary practice is with UW Health with privileges at UW Madison and UW Northern Illinois. His clinical interests are aggressive variants of thyroid cancer, parathyroid autofluorescence, and nerve monitoring.  Learning Objectives: 1) Learn about thyroid storm in hyperthyroidism and treatment options. 2) Understand how to treat hypercalcemic crisis due to uncontrolled primary hyperparathyroidism. 3) Describe the modified surgical techniques required for thyroidectomy in patients with Graves' disease to prevent recurrent laryngeal nerve traction injury. 4) Identify clinical and intraoperative indicators of parathyroid carcinoma and explain the necessity of en bloc resection to prevent parathyromatosis. References: 1 Palit TK, Miller CC 3rd, Miltenburg DM. The efficacy of thyroidectomy for Graves' disease: A meta-analysis. J Surg Res. 2000 May 15;90(2):161-5. doi: 10.1006/jsre.2000.5875. PMID: 10792958. https://pubmed.ncbi.nlm.nih.gov/10792958/ 2 Yoshimura Noh J, Inoue K, Suzuki N, Yoshihara A, Fukushita M, Matsumoto M, Imai H, Hiruma S, Ichikawa M, Koshibu M, Sankoda A, Hirose R, Watanabe N, Sugino K, Ito K. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil. Endocr J. 2024 Jul 12;71(7):695-703. doi: 10.1507/endocrj.EJ24-0135. Epub 2024 May 3. PMID: 38710619. https://pubmed.ncbi.nlm.nih.gov/38710619/ 3 Christopher L, Mellman M, Buicko JL. Management of Hypercalcemic Crisis due to Primary Hyperparathyroidism During Pregnancy. Am Surg. 2023 Aug;89(8):3638-3640. doi: 10.1177/00031348231162704. Epub 2023 Apr 27. PMID: 37102502. https://pubmed.ncbi.nlm.nih.gov/37102502/ Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content. Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Visionary vs. Integrator: The Two Types of Cash-Practice Entrepreneurs Clique away long enough and you lose your patient's attention. That's why Claire, our AI scribe built specifically for physical therapists, handles the documentation so you can focus on the person in front of you. Try it free at MeetClaire.ai. In this episode of the PT Entrepreneur Podcast, Dr. Danny breaks down two personality types that show up again and again inside cash-based practices: the Visionary and the Integrator. He explains why knowing your type gives you an immediate advantage, how it shapes your strengths, and which weaknesses can hold you back from scaling. What You'll Learn The difference between Visionaries and Integrators in a cash practice Why founders naturally lean toward one role—and how to spot yours Where each style excels (and where they struggle) Why early-stage entrepreneurs must build skills outside their comfort zone Two books that can change your trajectory depending on your type How to build momentum by pairing effort with accuracy Recommended Books For Integrators: How to Win Friends and Influence People For Visionaries: The Checklist Manifesto Key Takeaways Your natural wiring is an advantage—once you understand it. Visionaries need structure, systems, follow-through, and consistency. Integrators must learn the people-facing skills that drive business early on. Business growth accelerates when you focus effort on the right skills at the right time. You don't need more broad information—you need targeted learning and repetition. Want Personalized Guidance? If you want help identifying your strengths, gaps, and the clearest path to grow your cash practice, book a free call with a PT Biz senior advisor:

Send us a textTransitioning from fellowship to your first attending job? You're probably not prepared for the business side of medicine—and that's exactly the problem Dr. Tung Giep addresses in this episode. Dr. Giep, a neonatologist with over 30 years of experience, shares hard-earned lessons from building and selling a private practice in Houston, navigating toxic work environments, and eventually finding his place in telemedicine. His new book, The Business of Medicine: The Definitive Guide to Help New Physicians Start Their Career on the Right Path and Avoid Costly Mistakes, tackles what medical training ignores: contract negotiation, non-competes, choosing the right CPA and attorney, and understanding your self-worth.Ben and Dr. Giep discuss why new physicians get blindsided by job offers, how to vet a practice properly, and the reality of community neonatology versus academic medicine. They also explore the growing role of AI in healthcare and what it means for the next generation of physicians. Whether you're finishing fellowship or reconsidering your current position, this conversation offers practical guidance on taking control of your career—and avoiding costly mistakes along the way. Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode, Nathan A. Merriman, MD, MSCE, Interim Senior Medical Director of Surgical Specialties for the Digestive Health Clinical Program at Intermountain Medical Center, discusses how a patient-centered, team-based approach can improve access to care while enhancing the overall human experience. He shares insights on driving operational efficiency across surgical services and aligning clinical teams to deliver high-quality, coordinated care that meets patients where they are.

This episode breaks down the major misconceptions about ADHD treatment and clarifies what decades of research, major clinical guidelines, and leading experts actually recommend. Ryan and Mike explain why weekly talk therapy is not an evidence-based treatment for ADHD, why parent training and environmental structure are consistently shown to improve outcomes, and how parents can make informed decisions without getting pulled into common myths.Find Mike @ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.grownowadhd.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠IG⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Find Ryan @ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.adhddude.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ & on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Youtube{{chapters}}[00:00:00] Start[00:02:21] What clinical guidelines actually recommend[00:05:27] Dr. Barkley's research on effective ADHD treatments[00:09:11] Evidence on CBT, DBT, and play therapy[00:19:21] Why office-based therapy doesn't translate to real-world behavior[00:22:29] Rumination and how talk-heavy approaches can backfire[00:31:19] Treatments with the strongest evidence (medication, parent training)⁠⁠⁠Citations:1. AAP Guideline (Parent Training + Medication as First-Line)Wolraich, M. L., et al. (2019). Clinical practice guideline for ADHD in children and adolescents. Pediatrics, 144(4), e20192528.2. AACAP Treatment Parameter (Medication + Behavioral)Pliszka, S. R., & AACAP Work Group. (2007). Practice parameter for ADHD. JAACAP, 46(7), 894–921.3. Barkley: ADHD as Performance DisorderBarkley, R. A. (2012). Executive functions. Guilford Press.Barkley, R. A. (2015). ADHD: Handbook for diagnosis and treatment (4th ed.). Guilford Press.4. CBT Evidence (Adolescents/Adults, Not Young Children)Safren, S. A., et al. (2010). CBT vs relaxation for adults with ADHD. JAMA, 304(8), 875–880.Solanto, M. V. (2011). CBT for adult ADHD. Guilford Press.Langberg, J. M., et al. (2008). Organization skills intervention for adolescents. JCCP, 76(6), 967–982.5. DBT-Informed (Pilot Trials, Emotion Dysregulation)Murray, D. W., et al. (2022). DBT skills group for adolescents with ADHD. J Attention Disorders, 26(11), 1421–1430.6. Play Therapy (Insufficient Evidence)Hassan, R. A., & Shaker, N. S. (2014). CBPT for ADHD symptoms. Int J Psychology & Behavioral Sciences, 4(6), 221–229.7. EF Skills: Experience-Based, Not Language-BasedBarkley, R. A. (2012). Executive functions. Guilford Press.8. Rumination and ADHDOstojic, D., et al. (2021). Mind wandering and rumination in youth with ADHD. J Abnormal Child Psychology, 49, 1203–1216.Seymour, K. E., et al. (2014). Emotion regulation mediates ADHD-depression relationship. J Abnormal Child Psychology, 42, 611–621.9. Time Blindness/Temporal ProcessingToplak, M. E., & Tannock, R. (2005). Time perception deficits in ADHD. J Abnormal Child Psychology, 33(5), 639–654.Barkley, R. A., et al. (2008). ADHD in adults: What the science says. Guilford Press.10. Parent Behavior Training (Evidence-Based)Chronis, A. M., et al. (2006). Evidence-based treatments for children with ADHD. Clinical Psychology Review, 26(4), 486–502.Evans, S. W., et al. (2014). Evidence-based treatments for ADHD. JCCAP, 43(4), 527–551.11. Medication as First-LineFaraone, S. V., et al. (2021). Stimulant effectiveness and safety. World Psychiatry, 20(3), 314–329.Swanson, J. M., et al. (2017). MTA study long-term outcomes. JAACAP, 56(3), 228–240.

Vicky Gomersall is joined by Jay Bothroyd on today's episode of Sky Sports FC to discuss Arsenal's trophy aspirations this season.After reaching the Carabao Cup semi-finals by beating Crystal Palace on penalties, we ask whether Mikel Arteta's side need to improve in front of goal if they're to pick up trophies.Watch us live, Monday to Friday, 10am until Midday on Sky Sports News or listen to the podcast as soon as we come off air. To get involved you can send a voice note or message via WhatsApp to 07514 917075.For advertising opportunities email: skysportspodcasts@sky.uk.

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into the significant events of 2025, a year marked by pivotal scientific breakthroughs, regulatory changes, and industry trends that have reshaped drug development and patient care.One of the standout advancements was Novo Nordisk gaining FDA approval for an oral version of Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist for obesity management. This marks a notable shift in treatment accessibility, as it provides an easier alternative to injectables for those managing weight and cardiovascular risks. This development could significantly enhance patient adherence and broaden access to this critical therapy.However, not all news was positive. Pfizer faced a challenging situation when a patient death occurred in the extension of their Hympavzi hemophilia study. Such incidents highlight the intrinsic risks of clinical trials, especially within gene therapy realms where safety monitoring is paramount. These events remind us of the delicate balance between innovation and patient safety in advanced biologic therapies.In legal news, Johnson & Johnson was ordered by a Baltimore jury to pay $1.56 billion in a talc-related cancer case. This ruling underscores heightened scrutiny on product safety and consumer protection within the pharmaceutical industry, potentially influencing future litigation and regulatory measures.Clinical trial outcomes also presented mixed results. Neurocrine Biosciences' Ingrezza did not meet efficacy endpoints in its phase 3 trial for cerebral palsy-related dyskinesia. Although it is approved for other movement disorders, this setback reflects the complexities involved in expanding drug indications. Such challenges highlight ongoing hurdles in translating preclinical successes into clinical realities.Despite geopolitical tensions, particularly between China and the U.S., Chinese biotech firms thrived, maintaining robust deal activity. China's continued growth as an innovation hub is driven by strategic investments and collaborations that bolster global drug development efforts, underscoring its increasing influence in life sciences.Regulatory landscapes also shifted with proposals from the Center for Medicare & Medicaid Innovation to align U.S. drug prices with international rates under Medicare Parts B and D. These proposed models could significantly impact pricing strategies and market dynamics within the U.S., requiring pharmaceutical companies to adapt while ensuring equitable access to medications.Ethical challenges surfaced as six individuals were charged with insider trading involving biotech stocks. Such incidents highlight the necessity for stringent ethical standards and regulatory oversight to maintain investor confidence and market integrity.Meanwhile, AstraZeneca's extended partnership with Niowave for actinium-225 supply reflects an interest in radiopharmaceuticals as targeted cancer therapies. This collaboration highlights the potential of radiopharmaceuticals in oncology, opening promising avenues for precision medicine approaches.As 2025 closes, it's clear that this year has been one of both triumphs and trials for the pharmaceutical and biotech industries. Scientific innovations like Novo Nordisk's oral GLP-1 receptor agonist offer new hope for patients, yet challenges such as clinical trial setbacks and legal battles indicate ongoing hurdles in drug development and commercialization. These developments will likely influence industry strategies and regulatory policies as we advance into 2026.The sustained momentum of China's biotech industry amid global trade tensions remains notable. This trend reflects China's strategic investments in biotech capabilities and its growing role in global markets despite geopolitical frictions.In clinical research, Hope BioscienceSupport the show

Welcome to the Health Marketing Collective, where strong leadership meets marketing excellence.In today's episode, we're joined by Vasanta Pundarika, CEO of Lotuspring, a renowned healthcare investment banker, and trusted advisor to industry leaders who are working to bridge the gap between clinical conviction and sustainable scale—especially in women's and behavioral health. Hosted by Sara Payne, this powerful conversation dives deep into why so many healthcare brands are missing a pivotal movement in women's health, what it takes to truly earn women's trust, and how marketing, operations, and clinical teams can come together to create meaningful experiences that serve women holistically.Women's health is having a moment—but as Vasanta shares, it's more accurately a movement, driven by years of systemic gaps and a growing recognition that the status quo isn't enough. Despite the buzz, many organizations talk about leading in women's health without making necessary investments or creating real, differentiated experiences for female patients. A veteran in both finance and healthcare, Vasanta unpacks what ‘good' truly looks like when brands commit to women's health. From aligning marketing strategy with clinical substance, to collaborating across the C-suite, to acknowledging and addressing patient experience pain points—today's episode lays out a clear, actionable path for healthcare leaders and marketers ready to close the gap and build genuine, lasting trust with women.The discussion explores real-world pitfalls like “pink washing,” the underestimation of women's health complexity, and siloed planning between departments. Vasanta Pundarika also highlights industry standouts and the need for both niche and broad-based organizations to step up. Specific case studies in behavioral health, perimenopause, and cardiac care underscore the urgency of creating inclusive solutions, not just for women but for the health of families and communities at large.Thank you for listening to the Health Marketing Collective, where strong leadership meets marketing excellence. The future of healthcare depends on it.Key Takeaways:1. Move Beyond “Pink Washing”:Simply rebranding existing services or adding “women's health” messaging is not enough. Vasanta cautions against the pitfall of making things “pink” instead of developing real, differentiated clinical protocols and care pathways that address women's unique healthcare needs. Authenticity and substance, not symbolic gestures, win trust.2. Patient Experience Is the Product:Women's trust is built—or broken—in the details of the patient journey. Friction, complexity, or mismatched promises quickly erode brand loyalty. Brands that reduce barriers, provide holistic navigation, and deliver truly seamless experiences demonstrate that they “see” and value their female patients.3. Alignment Across Marketing, Clinical, and Operations Is Essential:Growth in women's health—and sustainable, trusted brands—requires collaborative strategy development. Vasanta recommends convening marketing, clinical, operations, and strategy leaders together to ensure what's being marketed is real, deliverable, and meaningfully distinct for women.4. Word of Mouth and Community Influence Are Powerful Drivers:The “voice of the customer”—listening to real women, collecting feedback, and amplifying their positive experiences—matters immensely in healthcare. Pilots, testimonials, and sharing what works for women allows brands to build authentic, organic trust and a broader community impact.5. Don't Underestimate the Scope of Women's Health Needs:Women's health extends far beyond OBGYN care. Behavioral health, heart health, and other specialties have unique female presentations and logistical barriers. Leaders must invest...

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Sex Differences in the Clinical Recognition of Significant Aortic Stenosis.

Join hosts Zach and Kevin for the annual Very Clinical holiday wrap-up! This week, they welcome back the recurring year-end duo, Dr. Erin Elliott and Dr. Gary Holtzclaw. It is officially a tradition as Erin and Gary join the guys to break down how they are spending the holidays and what has changed in their lives over the last twelve months. In this festive episode, the group shares their unique Christmas traditions, ranging from Icelandic rice pudding games to seafood feasts and tongue-in-cheek "virgin sacrifices." Beyond the holiday cheer, they dive into significant life updates. Kevin discusses the transition of selling his practice to become an associate and his growing obsession with pickleball. Erin shares the joys of empty nesting and her quest to visit every NFL stadium. Gary reveals why he deleted his social media accounts to reclaim his attention span and his commitment to taking real vacations, while Zach opens up about the realities of taking over full ownership of his family practice. It is a candid look at the personal and professional evolution of four dentists at different stages of their careers. Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Parenting and addiction are not two words you want in the same sentence, but unfortunately, addiction happens, and thus, parents need to know the facts about it. The Inherited Pattern of Addiction Addiction isn't just about individual choices; it often stems from generational patterns and dysfunction. Many people facing addiction today can trace their struggles back to influences and events in their family history. The interplay of epigenetics and unresolved emotional issues can shape how children are raised and how they handle challenges, impacting their potential for addiction. Recognizing Warning Signs in Children Parents might wonder what the early indicators of their child's potential addiction could be. It's essential to pay attention to changes in behavior, such as shifts in interests, friend groups, or academic performance. Unexplained isolation, carrying certain items everywhere, or noticeable changes in physical appearance can also signal underlying issues. Always trust your instincts; if you suspect something, there's often a valid reason behind it. The Role of Anxiety and Emotional Neglect Balancing Boundaries with Understanding Handling Older Children and Adult Addiction Relapse During the Holiday Season Holidays can amplify stressors, leading to a spike in relapses. Increased pressure, financial strain, and family dynamics can overwhelm someone in recovery. Families can support their loved ones by keeping celebrations manageable and straightforward, and avoiding substances that might trigger a relapse. Planning and open discussions about expectations can alleviate holiday-induced anxiety, helping maintain sobriety. Faith as a Pillar in Recovery About Kim Castro Kim Castro is committed to helping individuals, families, treatment programs, and addiction counselors develop and grow. She utilizes cutting-edge treatment modalities to deliver a gold standard of clinical care. For over a decade, Kim was the Executive Director of Recovery Outfitters, Inc. Kim is a certified master's-level counselor and certified clinical supervisor who instructs counselors seeking or maintaining credentials. She earned a master's degree in Conflict Management and a bachelor's degree in psychology from Kennesaw State University. Kim is recognized as a Subject Matter Expert in the field of addiction, even helping to revise the international master's-level certification for addiction counseling. In addition, she integrates both Faith-based and Clinical approaches to addiction treatment. Website for Kim Castro Read the full show notes and access all links. Additional Resources Download Kim's Guide on Helping vs. Enabling Book Recommendation: Boundaries by Dr. Henry Cloud and Dr. John Townsend

Clinical psychologist, educational leader, and author of Untethered: Creating Connected Families, Schools and Communities to Raise a Resilient Generation, Dr. Doug Bolton, joins me this week to unpack the rising levels of anxiety, burnout, and overwhelm we're seeing in kids today.   Together we explore:   - How changes in education starting in the 90s have intensified academic pressure for kids of all ages. - Why school avoidance, perfectionism, and burnout are rising, even among high-achieving students. - The neuroscience behind why rigor, overscheduling, and constant output make it harder for kids to access curiosity, regulation, and real learning. - How expectations have shifted, and why many kids simply aren't developmentally ready for what schools now demand. - Realistic, achievable ways to build rest, connection, and resilience into daily family life. - Small shifts parents can make at home to buffer their child's stress, protect their mental health, and restore balance.   If your child is melting down after school, anxious about grades, overwhelmed by homework, or feeling weighed down by pressure to perform, this episode will help you understand what's really going on beneath the surface and give you practical tools to support their wellbeing.     LEARN MORE ABOUT MY GUEST:

This episode, recorded live at the 10th Annual. Health IT + Digital Health + RCM Annual Meeting features Dr. Brian Patterson, Physician Administrative Director for Clinical AI, UW Health, who shares where AI is delivering real impact today in revenue cycle and clinical workflows and offers guidance on deploying AI responsibly amid rapid innovation and evolving governance.

In this episode, Coach Debbie Potts sits down with Dr. Zulia Frost, Co-Founder and Medical Director of Recharge Health, to explore how targeted red light therapy can support mitochondrial repair, thyroid function, gut health, liver detoxification, and overall metabolic resilience for adults navigating midlife. If you are in your 40s, 50s, 60s, or beyond and want to improve your energy, metabolism, hormone balance, digestion, and recovery, this conversation provides the education, tools, and strategies you need to optimize your health from the inside out. Zulia explains the science behind photobiomodulation, how red and near-infrared light activate cellular energy pathways, and why FlexBeam delivers medical-grade targeted therapy directly to organs and tissues that need it most. We break down the research on mitochondrial function, Hashimoto's and thyroid hormone conversion, gut inflammation, motility challenges, liver congestion, stress recovery, and active aging. This episode is especially relevant for midlife athletes, high performers, over-40 adults experiencing metabolic slowdown, and anyone wanting to age with strength, clarity, and vitality. Mentioned in the Episode FlexBeam by Recharge Health Try FlexBeam and save with code: CoachDebbiePotts Website: https://recharge.health (affiliate support is appreciated) Topics Covered • Why mitochondrial function declines with age and how red light supports ATP production • The connection between photobiomodulation and thyroid hormone activation • Clinical research on PBM for Hashimoto's and autoimmune thyroid dysfunction • Red light therapy for gut inflammation, motility, and microbiome balance • Liver detoxification, metabolic health, and targeted PBM application • Supporting the nervous system, vagal tone, sleep quality, and stress recovery • FlexBeam protocols for midlife athletes and active aging • How to integrate daily PBM routines into lifestyle, training, and recovery • Why targeted photobiomodulation works differently from full-body light panels About Zulia Frost Dr. Zulia Frost is a pioneer in photobiomodulation, neuromuscular rehabilitation, and integrative medicine. With more than two decades of clinical experience, she is internationally recognized for her work in cellular repair technologies and her scientific leadership at Recharge Health. Connect with Coach Debbie Potts Website: https://www.debbiepotts.net Podcast: The Coach Debbie Potts Show YouTube: https://www.youtube.com/@coachdebbiepotts Instagram: @coachdebbiepotts Email: coachdebbiepotts@icloud.com Support the Show If this episode helped you understand how to age stronger instead of slower, please rate, review, and share it with someone looking to improve their health, metabolism, and longevity.

In this episode, Gary Wörtz, MD, invites Damien Gatinel, MD, PhD, to share insights into online ophthalmic simulators and tools to help surgeons improve refractive planning. They explore tools for corneal ablation depth predictions, IOL rotation optimization, and more. Dr. Gatinel explains how these simulations can be applied to real-world patient counseling and help ophthalmologists understand what's going on with their patients.

In this episode, Nathan A. Merriman, MD, MSCE, Interim Senior Medical Director of Surgical Specialties for the Digestive Health Clinical Program at Intermountain Medical Center, discusses how a patient-centered, team-based approach can improve access to care while enhancing the overall human experience. He shares insights on driving operational efficiency across surgical services and aligning clinical teams to deliver high-quality, coordinated care that meets patients where they are.

In this episode, Nathan A. Merriman, MD, MSCE, Interim Senior Medical Director of Surgical Specialties for the Digestive Health Clinical Program at Intermountain Medical Center, discusses how a patient-centered, team-based approach can improve access to care while enhancing the overall human experience. He shares insights on driving operational efficiency across surgical services and aligning clinical teams to deliver high-quality, coordinated care that meets patients where they are.

BUFFALO, NY — December 23, 2025 — A new #research paper was #published in Volume 17, Issue 11 of Aging-US on November 25, 2025, titled “A natural language processing–driven map of the aging research landscape.” In this study, Jose Perez-Maletzki from Universidad Europea de Valencia and Universitat de València, together with Jorge Sanz-Ros from Stanford University School of Medicine, used artificial intelligence (AI) to analyze a century of global aging research, revealing shifts in focus and highlighting underexplored areas. The team analyzed over 460,000 scientific abstracts published between 1925 and 2023 to identify key themes, trends, and research gaps in the study of aging. Their goal was to provide a comprehensive, unbiased view of how the field has evolved and where future research could have the greatest impact. The study found that aging research has moved from basic cellular studies and animal models to a growing focus on clinical topics, particularly age-related diseases such as Alzheimer's and dementia. Using natural language processing and machine learning, the researchers grouped publications into thematic clusters and tracked how interest in each topic changed over time. “By integrating Latent Dirichlet Allocation (LDA), term frequency-inverse document frequency (TF-IDF) analysis, dimensionality reduction and clustering, we delineate a comprehensive thematic landscape of aging research.” One key finding was the growing separation between basic biological studies and clinical research. While both areas have grown significantly, they often progress independently with limited overlap. Clinical studies tend to focus on geriatrics, healthcare, and neurodegenerative diseases, while basic science emphasizes cellular mechanisms such as oxidative stress, telomere shortening, mitochondrial dysfunction, and senescence. The authors note that this lack of integration limits the translation of laboratory discoveries into medical applications. The study also showed that some emerging topics, such as autophagy, RNA biology, and nutrient sensing, are expanding rapidly but remain separated from clinical applications. In contrast, long-established links, such as those between cancer and aging, remain strong. The analysis also highlighted that potentially important associations, such as those between mitochondrial dysfunction and senescence or epigenetics and autophagy, are rarely studied and may be new research opportunities. This AI-driven analysis offers a new way to guide future research by identifying how different areas of aging science are interconnected or isolated. It also highlights how research priorities may be shaped by policy or funding trends, as seen in the heavy focus on Alzheimer's disease. As the global population continues to age, understanding how biological processes relate to clinical outcomes is critical. This study not only offers a historical map of aging science but also serves as a tool to support more connected, interdisciplinary, and effective future research. DOI - https://doi.org/10.18632/aging.206340 Corresponding author - Jorge Sanz-Ros - jsanzros@stanford.edu Abstract video - https://www.youtube.com/watch?v=O4dJUGQ2ZcU Subscribe for free publication alerts from Aging - https://www.aging-us.com/subscribe-to-toc-alerts To learn more about the journal, visit https://www.Aging-US.com​​ and connect with us on social media at: Bluesky - https://bsky.app/profile/aging-us.bsky.social ResearchGate - https://www.researchgate.net/journal/Aging-1945-4589 Facebook - https://www.facebook.com/AgingUS/ X - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ LinkedIn - https://www.linkedin.com/company/aging/ Reddit - https://www.reddit.com/user/AgingUS/ Pinterest - https://www.pinterest.com/AgingUS/ YouTube - https://www.youtube.com/@Aging-US Spotify - https://open.spotify.com/show/1X4HQQgegjReaf6Mozn6Mc MEDIA@IMPACTJOURNALS.COM

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

John E. Anderson, MD / Richard J. Auchus, MD, PhD - Hypercortisolism and Difficult-to-Treat Cardiometabolic Disease: Therapeutic Developments and Clinical Advances Driving Meaningful Improvement in Patient Outcomes

In this episode of the MaternalRX podcast on the Pharmacy Podcast Network, Danielle sits down with Dr. Tadeh Vartanian, a Pharmacist and Medical Lead with deep expertise in autoimmune diabetes. Drawing on years of clinical practice and research, Dr. Vartanian explains why early detection and precise diabetes classification can dramatically shift outcomes for people who are pregnant, planning pregnancy, or managing complex metabolic risks. This conversation delivers a practical, up-to-date overview of diabetes types, maternal risk considerations, screening strategies, and the emerging science behind autoimmune and genetic diabetes. And if you have never heard of monogenic diabetes, you will want to hear this episode! Understanding this category can immediately change how clinicians diagnose and treat patients. Diabetes types explained - How to differentiate type 1 diabetes, type 2 diabetes, gestational diabetes, and monogenic diabetes - Why type 1 is autoimmune and what loss of 80 to 90 percent of beta cells means for patient management - The phases of type 1 diabetes and the predictive power of autoantibodies - How monogenic diabetes presents differently and when to consider genetic testing - Which diabetes types can improve with targeted lifestyle interventions Diabetes screening and diagnostic testing - Why early screening is the most impactful action clinicians can take - When to use hemoglobin A1C, fasting glucose, and the oral glucose tolerance test - A clear explanation of the 50-gram and 100-gram Glucola tests used in gestational diabetes screening and diagnosis - How to identify autoimmune diabetes using autoantibody testing Autoantibody screening programs - TrialNet: the NIDDK-supported program offering at-home screening for people with a first-degree relative with type 1 diabetes - ASK (Autoimmunity Screening for Kids): now expanded to adults, with nationwide access through the University of Colorado laboratory - How these programs detect autoimmune diabetes before symptoms develop Genetics, autoimmunity, and diabetes research - How new genetic testing is reshaping the identification of monogenic diabetes - What autoimmune activity means in type 1 diabetes and why early detection matters - Current research, evolving guidelines, and clinical trial insights relevant to maternal health and diabetes care Diabetes and pregnancy - How diabetes influences pregnancy outcomes and why classification accuracy is critical - The long-term significance of gestational diabetes and its link to future type 2 diabetes - Clinical considerations for preconception counseling, prenatal care, and postpartum metabolic health - How maternal diabetes affects the long-term health trajectory of both parent and child Key takeaway from Dr. Vartanian: Screen early and use the right tools. Identifying diabetes risk before symptoms appear can change the course of care at every stage of pregnancy. Connect with our guest and host: - Dr. Tadeh Vartanian: www.linkedin.com/in/tadehvartanian/ - Dr. Danielle Plummer: www.linkedin.com/in/daniellerplummer/

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

In this episode of Better Edge, Chandrika Shankar, MD, explores the dynamic intersection of mental health and law. Learn how forensic psychiatrists assess competency, navigate ethical dilemmas and balance risk assessment tools with clinical judgment. Dr. Shankar also shares insights on telepsychiatry, AI-assisted evaluations and the core skills needed to succeed in this evolving field.

Each year on TheBodyPro, David Alain Wohl, M.D., of the University of North Carolina summarizes and analyzes the 10 new studies and noteworthy events that he feels are most likely to have a palpable impact on the way we approach HIV prevention, treatment, and patient care in the U.S. And each year on this podcast, we welcome Dr. Wohl for a discussion about these keystone moments and their import.   Read the transcript: https://www.thebodypro.com/podcast/hiv/future-hiv-care-top-10-david-wohl-dec-2025   Peruse Dr. Wohl's picks: https://www.thebodypro.com/collection/top-10-2025-hiv-clinical-developments   This podcast is hosted and executively produced by Myles Helfand, TheBodyPro's executive editor; our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; and our audio editor is Kim Buikema.

Julie A. Parsons, MD Haberfield Endowed Chair in Pediatric Neuromuscular DisordersProfessor of Clinical Pediatrics and NeurologyUniversity of Colorado School of Medicine, Children's Hospital ColoradoAurora, CO, USAAs we talk about the gene transfer therapies and the modalities that we have to use, it's really interesting. Yesterday, with our keynote speaker, you could see this logarithmic growth of the use of gene transfer therapies for these disorders. If you look at the Venn diagram, you can see that really 27% almost of gene transfer therapies that are used are in musculoskeletal and neurology. For many of us as neurologists, we also take care of metabolic disorders.We really own right now this landscape, and of course, our two approved modalities are Onasemnogene and Delandistrogene. We're going to look at three different disorders, monogenic disorders, monogenic diseases, to typify what we look at in terms of some of the risks and benefits of these treatments. SMA, Duchenne, and X-linked myotubular myopathy are all rare disorders. They're all diseases that have a high unmet medical need and a significant disease burden.I think they're all good in terms of typifying where we are clinically with these disorders. The first question is, is it worth it? Are these effective treatments? We know from looking at the information about SMA that just looking early on, we know that if we treat kids early, that we do see a marked improvement in motor scores for kids that are treated early with Onasemnogene.In Duchenne, we have information that there is at least some improvement in the 4-5-year-olds in terms of motor skills treated with Delandistrogene. In terms of X-linked MTM, which was a very dramatic improvement, you could see that for boys who were basically traked, vented, and had no mobility, the bottom line, the blue line, is actually looking at ventilator dependence. Are they effective? Yeah, they're effective, but then we have to say, okay, what's the downside?The downside is that there's tremendous risk associated with treatment with these agents. If we really look at the sobering facts, we know that with SMA, there have been deaths, there have been fatalities related to thrombotic microangiopathy to patients who have liver failure, a couple of patients have died. With Onasemnogene, this is 4,000 plus doses that have so far been given. With Duchenne, unfortunately, many of us got the letter yesterday talking about an additional death in a patient treated with commercial Delandistrogene.We also know with some of the other agents, like fordadistrogene, patient died of heart failure, cardiac arrest, another patient who had acute respiratory syndrome with pulmonary edema. Again, we look at this and say this is significant. With X-linked MTM, as Alan said, there were some unanticipated deaths, four deaths from patients who ended up having cholestatic liver diseases that really wasn't anticipated prior to the patients being treated with the animal models and all that we had. Then many of you have heard about the patient with Rett syndrome who had a systemic hyperinflammatory syndrome. Again, these are rare disorders. They have a high disease burden, but the risk of treatment is significant.In the next part, Dr. Parsons discuss factors impacting safety and efficacy of AAV-mediated gene therapies.

Welcome to "Labor & Delivery Debrief," the podcast where we tackle your toughest questions about childbirth and maternal health. Today, we're diving deep into a fascinating and critical topic sent in by one of our listeners, Sarah. Sarah asks: "Is it possible for a clinical diagnosis of chorioamnionitis to not be confirmed by placental histology? And if so, how is that possible?" This is a fantastic question that touches on the complexities of intrapartum clinical diagnosis of intraamniotic infection (IAI), also commonly known as chorioamnionitis. We'll explore the nuances of clinical versus histological findings, the diagnostic criteria, and why these two assessments don't always perfectly align. Get ready for a detailed discussion that will shed light on this important aspect of obstetric care.1. ACOG CO 712; 2017 (2025)2. Romero R, Pacora P, Kusanovic JP, et al. Clinical Chorioamnionitis at Term X: Microbiology, Clinical Signs, Placental Pathology, and Neonatal Bacteremia - Implications for Clinical Care. Journal of Perinatal Medicine. 2021;49(3):275-298. doi:10.1515/jpm-2020-0297.3. Jung E, Romero R, Suksai M, et al. Clinical Chorioamnionitis at Term: Definition, Pathogenesis, Microbiology, Diagnosis, and Treatment. AJOG. 2024;230(3S):S807-S840. doi:10.1016/j.ajog.2023.02.002.4. Oh KJ, Kim SM, Hong JS, et al. Twenty-Four Percent of Patients With Clinical Chorioamnionitis in Preterm Gestations Have No Evidence Of either Culture-Proven Intraamniotic Infection Or intraamniotic Inflammation. AJOG. 2017;216(6):604.e1-604.e11.

In this episode, Hallie Bulkin speaks with Dr. Alyssa Welch about the vital role of interprofessional collaboration in achieving optimal patient outcomes, particularly for speech-language pathologists (SLPs). Dr. Welch emphasizes that working alongside occupational therapists (OTs), physical therapists (PTs), dentists, and other specialists is not just beneficial—it is now a core competency in modern healthcare.Dr. Welch and Hallie discuss the necessity of recognizing the limits of your own expertise and knowing when to make a referral. Collaboration ensures a whole-person therapeutic approach and prevents the professional burnout that comes from trying to "fix everything" in isolation. They cover key areas where SLPs and other therapists must coordinate care, such as feeding mechanics, positioning for speech, and addressing core stability and motor skills.In this episode, you'll learn:✔️ ️ Interprofessional collaboration is essential for SLPs, leading to better patient outcomes and reduced medical errors.✔️ Collaboration often involves partnering with Occupational Therapists (OTs) for fine motor skills, positioning, and feeding mechanics, and Physical Therapists (PTs) for gross motor skills, body positioning, and trunk control.✔️ Collaboration shifts the focus from checking off individual treatment boxes to a patient-centered approach that meets the family's actual needs.✔️ Poor communication is responsible for an estimated 70-80% of serious medical errors; collaboration significantly reduces this risk.✔️ Recognizing the limits of your own scope and knowing when to refer is crucial for long-term career sustainability and preventing professional burnout.✔️ Clinical collaboration can take many forms, including email consultations, case conferences, co-treatment sessions, and shared documentation.RELATED EPISODES YOU MIGHT LOVEEpisode 234: The Role of Occupational Therapists in TOTs Care with Anna Dearman MBA, MOT, LOTR, CLCEp 332: The Interconnectedness of Oral and Systemic Health with Amber White RDH, HHPOTHER WAYS TO CONNECT & LEARN

Welcome to the latest episode of L.I.F.T.S, your bite‑sized dose of the Latest Industry Fitness Trends and Stories. In this episode, hosts Matthew Januszek and Mohammed Iqbal sit down with Mohit Kumar, Co‑Founder and CEO of Ultrahuman, to explore the explosive rise of smart rings and the future of wearable health technology. Topics covered include: Mohit's unconventional founder journey and early days in metabolic health. Why smart rings are outperforming other wearables in growth. Ultrahuman's approach to sleep, metabolism, and biomarkers. The high‑stakes patent battle with Oura and the U.S. import ban. What resilience really looks like for founders. The future of AI, battery life, and ring‑based health tracking. Why sleep is becoming the most important performance metric.

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

In this episode, Anthony J. Tortolani, MD, FACS, FACC, Cardiac and Thoracic Surgeon and Professor Emeritus of Clinical Cardiothoracic Surgery at Weill Cornell Medical College, discusses the realities of declining profit margins and how leaders are balancing financial pressures with clinical excellence. He explores practical applications of AI in clinical medicine, including improvements in efficiency and less invasive surgical approaches, and shares why aligning strategic vision with day-to-day tactical planning is essential for long-term success in cardiovascular care.

In his weekly clinical update, Dr. Griffin and Vincent Racaniello protest Vinjay Prasad, head of CBER FDA Nov memo stating administration of the COVID-19 vaccine resulted in 10 children's deaths, but are cautiously delighted by the December memo from those in CBER who dispute this data-less claim, how in 31 states pertussis vaccination rates have declined before Dr. Griffin then deep dives into recent statistics on the measles epidemic, RSV, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, Johns Hopkins measles tracker, of clinical outcomes of oseltamivir versus baloxavir for treating influenza infection, number deaths associated with COVID-19 hospitalizations and disease associated economic burden, where to find PEMGARDA, how to access and pay for Paxlovid, long COVID treatment center, where to go for answers to your long COVID questions, how the German government is committed to research into long COVID and contacting your federal government representative to stop the assault on science and biomedical research. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Industry laments Prasad vaccine memo (Politico) Scoop: FDA vaccine chief's memo cited 10 pediatric Covid-19 vaccine deaths—but the agency's own analysis found 0–7 (Inside Medicine) Whooping cough cases soar as vaccination rates drop (NBC News) Marburg Outbreak in Ethiopia: Current Situation (CDC: Marburg Virus Disease) Wastewater for measles (WasterWater Scan) Measles cases and outbreaks (CDC Rubeola) Tracking Measles Cases in the U.S. (Johns Hopkins) Measles vaccine recommendations from NYP (jpg) Weekly measles and rubella monitoring (Government of Canada) Measles (WHO) Get the FACTS about measles (NY State Department of Health) Measles(CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts (ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) Hundreds quarantined as South Carolina measles outbreak accelerates (Washington Post) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) USrespiratory virus activity (CDC Respiratory Illnesses) Respiratory virus activity levels (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) In call with clinicians, CDC recommends flu vaccines widely (CIDRAP) Influenza Vaccine Composition for the 2025-2026 U.S. Influenza Season (FDA) Comparison of clinical outcomes of oseltamivir versus baloxavir in outpatients with influenza: a retrospective cohort analysis (International Journal of Infectious Diseases) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Respiratory Diseases (Yale School of Public Health) USrespiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Vaccines for Adults (CDC: Respiratory Syncytial Virus Infection (RSV)) Economic Analysis of Protein Subunit and mRNA RSV Vaccination in Adults aged 50-59 Years (CDC: ACIP) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) Respiratory Illnesses Data Channel (CDC: Respiratory Illnesses) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV) Effectiveness of 2024–2025 COVID-19 Vaccines in Children in the United States — VISION, August 29, 2024–September 2, 2025 (CDC:MMWR) Mortality following recovery from COVID-19 hospitalization: A long-term cohort study (International Journal of Infectious Diseases) COVID hospitalization tied to 69% higher risk of death for up to 2 years (CIDRAP) Where to get pemgarda (Pemgarda) EUAfor the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Help your eligible patients access PAXLOVID with the PAXCESS Patient Support Program (Pfizer Pro) Understanding Coverage Options (PAXCESS) Infectious Disease Society guidelines for treatment and management (ID Society) Comparison of work productivity losses in the United States among employees with COVID-19 at high-risk of severe disease who were untreated or treated with nirmatrelvir/ritonavir (Journal of Medical Economics) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) Managing healthcare staffing shortages (CDC) Anticoagulationguidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Long-COVID research just got a big funding boost: will it find new treatments?(Nature) Reaching out to US house representative Letters read on TWiV 1280 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

Pharmacists can be essential in managing myasthenia gravis by providing education, identifying exacerbating medications, offering therapeutic alternatives, and supporting overall appropriate pharmacotherapy. This podcast provides pharmacists with an understanding of the pathophysiology of myasthenia gravis and myasthenic crisis, common complications associated with the disease state, and useful medication management considerations for the emergency department setting. CE for this episode expires on December 20, 2027.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Send us a textA small structural “bump” on a molecule might be the big breakthrough EPM care has been waiting for. We sit down with researcher and clinician Izabela de Assis Rocha to unpack how bumped kinase inhibitors exploit a tiny difference between parasite and mammalian kinases to hit Sarcocystis neurona where it hurts—motility, invasion, and replication—while sparing the horse. It's a molecular strategy with practical promise, and the conversation bridges the stall, the lab, and the future of equine neurology.We break down the science behind CDPK1, the gatekeeper residue that drives selectivity, and why unique parasite structures like the apical complex and apicoplast open new therapeutic lanes. Then we move into what really matters for care: pharmacokinetics and clinical fit. BKI-1708 shows strong systemic distribution that positions it as a prophylactic candidate, while early data on BKI-1553 suggests better CNS penetration and a path toward active EPM treatment. Isabella explains how EPM's dead-end host biology may lower the risk of widespread resistance, a rare bright spot in the antiparasitic landscape.Clinical trials are the hard part. With no robust experimental infection model and fewer than 1% of exposed horses developing disease, enrolling enough cases takes patience and teamwork. We talk about building pragmatic, clinician-led studies, harmonizing diagnostics and neurologic scoring, and tracking relapse to find outcomes that matter to horses and owners. The One Health angle also shines through: BKIs show activity against equine piroplasmosis and have potential roles in toxoplasmosis and cryptosporidiosis, linking equine research to human and livestock health.If you care about evidence-based equine neurology, new antiparasitic strategies, and turning elegant biochemistry into barn-side change, this is your roadmap. Subscribe, share with a colleague who manages EPM cases, and leave a review to help more veterinarians find the show. What question would you ask about bringing BKIs into practice?AJVR article: https://doi.org/10.2460/ajvr.25.07.0270INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ® OR AJVR ® ? JAVMA ® : https://avma.org/JAVMAAuthors AJVR ® : https://avma.org/AJVRAuthorsFOLLOW US:JAVMA ® : Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook Instagram: JAVMA (@avma_javma) • Instagram photos and videos Twitter: JAVMA (@AVMAJAVMA) / Twitter AJVR ® : Facebook: American Journal of Veterinary Research - AJVR | Facebook Instagram: AJVR (@ajvroa) • Instagram photos and videos Twitter: AJVR (@AJVROA) / Twitter JAVMA ® and AJVR ® LinkedIn: https://linkedin.com/company/avma-journals

In this episode, Marcus Perez, President of Altera Digital Health, discusses how trusted, well governed data is the foundation for meaningful AI adoption in healthcare. He shares practical use cases around ambient documentation, workflow improvement, value based care, and why AI driven progress must evolve at the pace of clinicians and organizations.This episode is sponsored by Altera Digital Health.

In a wide-ranging, high-octane interview, Hall of Famer Rick Pitino joins Brandon Tierney to discuss the state of St. John's basketball and his storied career. Pitino gets brutally honest about his current squad, admitting they lack the veteran dominance of last year's team and issuing a public challenge to Bryce Hopkins to become an "alpha dog" or risk his NBA dreams. The conversation turns fiery and nostalgic as Pitino recounts a "hysterical" story from the birth of WFAN, remembering how "clinical moron" callers wanted him fired while his Knicks were in first place. The Coach also settles New York's greatest debates, naming Pearl Washington and Kenny Anderson as the ultimate handles and Chris Mullin as the city's premier marksman. To wrap it up, BT shares a legendary personal story of an all-night bar session with Pitino that felt like a scene straight out of The Godfather.

Dr. Gent is an accomplished clinician and expert in psychotherapeutic development with a distinguished career that spans over two decades. He is currently the Chief Clinical Officer at Pacific Quest where he oversees the Clinical program, ensuring the highest standards of care and leading a dedicated team of professionals.In This EpisodeRob's websitePacific Quest on FacebookPacific Quest on YoutubeBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-trauma-therapist--5739761/support.You can learn more about what I do here:The Trauma Therapist Newsletter: celebrates the people and voices in the mental health profession. And it's free! Check it out here: https://bit.ly/4jGBeSa———If you'd like to support The Trauma Therapist Podcast and the work I do you can do that here with a monthly donation of $5, $7, or $10: Donate to The Trauma Therapist Podcast.Click here to join my email list and receive podcast updates and other news.Thank you to our Sponsors:Incogni - Use code [traumatherapist] and get 60% off annual plans: https://incogni.com/traumatherapistJane App - use code GUY1MO at https://jane.app/book_a_demoJourney Clinical - visit https://join.journeyclinical/trauma for 1 month off your membershipTherapy Wisdom - https://therapywisdom.com/jan/

[We weren’t available to record a new show for you this week, so enjoy this rerun instead!] Clinical students are sometimes the only ones who have time to listen In the clinic, med students can feel like bystanders, but they can make all the difference for patients. M3 Jeff Goddard, M3 Tracy Chen, M2 Alex Nigg, and M4 Matt Engelken recount stories of the patients that stuck with them—some painful, some beautiful, and some just plain awkward. From OB-GYN to peds to the ER, they share how student doctors—who can often feel like tagalongs—can often be the ones offering emotional support, catching critical miscommunications, or just being the one person with time to care. We reflect on the pressure to look competent, the sting of lukewarm evaluations, and how one med student realized a patient wasn't constipated—just heartbroken. Also in this episode: talking to dying patients, babies are scary, and what not to say when to overwhelmed family. Episode credits: Producer: Dave Etler Co-hosts: Matt Engelken, M4; Jeff Goddard, M3; Tracy Chen, M3; Alex Nigg, M2 We Want to Hear From You: YOUR VOICE MATTERS! We welcome your feedback, listener questions, and shower thoughts. Do you agree or disagree with something we said today? Did you hear something really helpful? Can we answer a question for you? Are we delivering a podcast you want to keep listening to? Let us know at https://theshortcoat.com/tellus and we'll put your message in a future episode. Or email theshortcoats@gmail.com. The Short Coat Podcast is FeedSpot’s Top Iowa Student Podcast, and its Top Iowa Medical Podcast! Thanks for listening! We do more things on… Instagram: https://www.instagram.com/theshortcoat YouTube: https://www.youtube.com/theshortcoat You deserve to be happy and healthy. If you’re struggling with racism, harassment, hate, your mental health, or some other crisis, visit http://theshortcoat.com/help, and send additions to the resources there to theshortcoats@gmail.com. We love you. Music provided by Argofox. License: bit.ly/CCAttributionDOCTOR VOX – Heatstroke: youtu.be/j1n1zlxzyRE Catmosphere – Candy-Coloured Sky: youtu.be/AZjYZ8Kjgs8Hexalyte – Wandering Hours: youtu.be/FOAo2zsYnvA

Dr. Sausha Toghranegar takes a deep dive into osseodensification and its role in crestal sinus lifts. He breaks down the evolution and design of osseodensification drills, addresses common controversies, and shares practical techniques for improving implant outcomes. Through a detailed case study, Dr. Toghranegar highlights the importance of understanding bone density, healing dynamics, and proper surgical execution. The episode wraps with insight into emerging learning opportunities and what's next in this advancing area of dental surgery.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, welcomes William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent news updates and key advancements shaping the industry in 2025.Staying healthy during the holidays (00:18): Discover how to protect yourself and others as a new influenza strain, holiday gatherings, and increased travel raise the risk of spreading viruses. 2025 breakthroughs and trends (04:31): Learn more about the technologies, regulations, and innovation influencing the future of clinical diagnostics. Note: Information in this post was accurate at the time of its posting.Resources"Answers From the Lab” podcast: Innovations Set to Shape the Industry in 2025Dr. Morice shares trends and predictions for 2025Mayo Clinic Minute: How to prepare for the influenza seasonMayo Clinic Minute: Wash your hands for better healthVaccines and viruses: Protecting health across generations

The last clinical corner article of 2025! Matt and Allie are back to discuss this month's article about a familiar topic: Prehab! This specific article is a literature review that gathers information from thousands of cases and reports covering controlled trials that compared treatments for total hip and total knee surgeries. Matt poses his monthly question to PT students listening, and describes the findings in the article. Read the article here: https://www.jospt.org/doi/10.2519/jospt.2025.13075Are you a current/past patient tuning in from the link in your email? Leave a comment on our socials and share this with a friend! Have a question or are looking to start prehab for yourself? Contact us here: https://www.oxfordphysicaltherapy.com/ask-a-questionDid you know that you don't need a doctor's prescription to receive physical therapy? The laws of Direct Access allow you to receive physical therapy without a referral and still use your insurance benefits! Learn more on how Direct Access can help YOU! Our website: https://www.oxfordphysicaltherapy.com/

Kevin and Alan are joined again by Dr. Dhaval Patel to discuss the significant shifts occurring in digital dentistry, moving beyond the traditional CEREC workflow. Dhaval explains that his highly popular online group, "Keep CERECing," was recently renamed "Keep CAD/CAMing" after he consulted with Dentsply Sirona's legal team regarding trademark usage, which prompted him to broaden the group's scope. This change has led to a natural expansion in technology focus, now encompassing the wider CAD/CAM landscape including 3D printing and 5-axis milling. Dhaval details how he uses 3D printing for models, surgical guides, and night guards, and leverages a 5-axis mill for larger, multi-unit cases and zirconia restorations, highlighting the cost efficiency and ability to run large jobs overnight. The conversation also explores the rise of dedicated, outsourced digital designers and the potential for artificial intelligence (AI) to handle design in the near future. Some links from the show: Keep CADCAMing Facebook group Dhaval's Instagram Keep CADCAMing website (where you can find information about their upcoming meeting October 15-17th, 2026!) Join the Very Clinical Facebook group!  Join the Very Dental Facebook Group using one of these passwords: Timmerman, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, or Lipscomb!  The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

This is a fan fav episode. When you think of cultural beliefs, how often have you found yourself questioning where these beliefs stem from? My guest today explores the notion of cultural lies that are at the root of our suffering as a society and as individuals. Clinical psychologist, Dr. Shefali shares some of her most profound insights from her latest book, A Radical Awakening. Witness her working through some ideas with me in real time around the culture being the villain versus owning your internal life and consciousness. Dive into some of the deeper ideas Dr Shefali presents starting with recognizing our destructive animal nature. Order Dr. Shefali's book, A Radical Awakening: ⁠https://www.aradicalawakening.com/⁠  Original air date: 6-22-2021 SHOW NOTES: 0:00 | Introduction to Dr. Shefali 2:16 | Layers of Radical Awakening 3:29 | Our Animal Nature & Biological Wiring 8:06 | Our Destructive Nature to Justify 9:42 | Learn To Be Interconnected in Consciousness 13:50 | Chasing Dominance & Delusional Cravings 16:13 | Insecurities & Endless Consumerism 18:51 | Women Not Fitting The Beauty Standard 22:19 | Learning to Accept Yourself 25:32 | Dr. Shefali Explains the Toxic Patriarchy 33:20 | Women Buffering Against the Patriarchal System 36:36 | The Effects of Unconsciousness of Culture 39:57 | Who is Culture? What Toxicity Are You Buying? 41:35 | Navigating the Toxic Beliefs From Culture 44:05 | Dr. Shefali on Cultivating Your Own Voice 47:51 | Awakening to The Marriage Contract 52:07 | The Lie of Monogamy in Culture 53:28 | Our Insecurity That Drives Domination 54:51 | Realizing Self Worth and Self Acceptance  Learn more about your ad choices. Visit megaphone.fm/adchoices